INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate of 1.45% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2025 was 1.45%, a 27.19% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2024 was 1.14%, a 24.50% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2023 was 1.51%, a 38.11% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2022 was 2.44%, a 559.46% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 12 month |
|---|---|
| 2025-12-31 | 1.45% 10-K · filed 2026-02-26 |
| 2024-12-31 | 1.14% 10-K · filed 2026-02-26 |
| 2023-12-31 | 1.51% 10-K · filed 2026-02-26 |
| 2022-12-31 | 2.44% 10-K · filed 2024-02-28 |
| 2021-12-31 | 0.37% 10-K · filed 2023-02-22 |
| 2020-12-31 | 0.34% 10-K · filed 2022-02-24 |
| 2019-12-31 | 0.40% 10-K · filed 2021-02-23 |
| 2018-12-31 | 1.00% 10-K · filed 2020-02-21 |
| 2017-12-31 | 0.74% 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |